| __timestamp | TG Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 17992000000 |
| Thursday, January 1, 2015 | 19886580 | 22400000000 |
| Friday, January 1, 2016 | 12631689 | 23910000000 |
| Sunday, January 1, 2017 | 21977998 | 23813000000 |
| Monday, January 1, 2018 | 20759000 | 24694000000 |
| Tuesday, January 1, 2019 | 20838000 | 23557000000 |
| Wednesday, January 1, 2020 | 121812000 | 25436000000 |
| Friday, January 1, 2021 | 152137000 | 24586000000 |
| Saturday, January 1, 2022 | 83231000 | 27295000000 |
| Sunday, January 1, 2023 | 122706000 | 34205000000 |
| Monday, January 1, 2024 | 28113000000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding the financial dynamics of key players is crucial. From 2014 to 2023, Walgreens Boots Alliance, Inc. consistently demonstrated robust spending on Selling, General, and Administrative (SG&A) expenses, peaking at approximately $25.5 billion in 2023. This represents a steady increase of around 44% from 2014. In contrast, TG Therapeutics, Inc., a smaller biotech firm, showed a more volatile trend, with SG&A expenses surging by nearly 400% from 2014 to 2023, reaching about $122 million. This disparity highlights the scale and strategic differences between a retail giant and a nimble biotech company. Notably, data for 2024 is incomplete, reflecting the dynamic nature of financial reporting. These insights offer a window into the strategic priorities and operational scales of these two distinct industry players.
Gilead Sciences, Inc. or Walgreens Boots Alliance, Inc.: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. and Walgreens Boots Alliance, Inc.: SG&A Spending Patterns Compared
Genmab A/S vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Insmed Incorporated vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Walgreens Boots Alliance, Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. vs Verona Pharma plc: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Vericel Corporation
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated Trends and Insights
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs ImmunityBio, Inc. Trends and Insights